The alternative scenario—that is, that P2Y1R inhibition decreases Stat3 activation and that the reduced calcium hyperactivity occurs downstream of this event—is less likely, as P2Y1R inhibition normalizes calcium activity in AD models within minutes (Delekate et al, 2014; Reichenbach et al, 2018). Here, STAT3 is linked to Alzheimer disease.